The Curie Institute, a renowned French research center focused on cancer and other diseases, is currently developing what it calls an "electronic nose." This device aims to detect breast cancer at an early stage by analyzing the molecules present in human sweat. The concept is inspired by the way animals use their sense of smell to detect changes in their environment, and the goal is to apply this principle to medical diagnostics. The electronic nose is still in the research and development phase. Scientists at the institute have not yet created a working prototype. Instead, they are first working to identify the specific molecules in sweat that are associated with breast cancer. This process involves collecting and analyzing sweat samples from patients, both with and without the disease, to find patterns or biomarkers that could be used for detection. This research is part of a broader effort to develop non-invasive and rapid diagnostic tools for cancer. If successful, the electronic nose could offer a simple and painless method for early detection, which is crucial for improving treatment outcomes. However, the team acknowledges that this is a complex and long-term project that will require further studies and validation before it can be used in clinical settings. While the idea of an electronic nose may seem futuristic, similar technologies are already being explored in other areas, such as detecting diseases through breath analysis or identifying environmental pollutants. The Curie Institute hopes that their work will contribute to a new generation of diagnostic tools that are more accessible and efficient.